| scholarly article | Q13442814 |
| P2093 | author name string | Erica A Golemis | |
| Emmanuelle Nicolas | |||
| Tim N Beck | |||
| Meghan C Kopp | |||
| P2860 | cites work | Direct interaction between Smad3, APC10, CDH1 and HEF1 in proteasomal degradation of HEF1 | Q21284174 |
| Overexpression of s6 kinase 1 in brain tumours is associated with induction of hypoxia-responsive genes and predicts patients' survival | Q21296638 | ||
| NEDD9 stabilizes focal adhesions, increases binding to the extra-cellular matrix and differentially effects 2D versus 3D cell migration | Q21561000 | ||
| Tau interacts with src-family non-receptor tyrosine kinases | Q22003901 | ||
| Cancer genome landscapes | Q22242276 | ||
| Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease | Q22248076 | ||
| Alzheimer's Disease | Q22248111 | ||
| TREM2 Variants in Alzheimer's Disease | Q22250873 | ||
| Variant of TREM2 Associated with the Risk of Alzheimer's Disease | Q22250874 | ||
| Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 | ||
| Alzheimer mechanisms and therapeutic strategies | Q22252311 | ||
| Tau pathology in Alzheimer disease and other tauopathies | Q22252520 | ||
| Appraising the brain's energy budget | Q22337193 | ||
| Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions | Q24307776 | ||
| A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation | Q24312845 | ||
| Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases | Q24316242 | ||
| Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease | Q24316501 | ||
| Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells | Q24317734 | ||
| Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae | Q24323041 | ||
| Tyrosine phosphorylation of Crk-associated substrates by focal adhesion kinase. A putative mechanism for the integrin-mediated tyrosine phosphorylation of Crk-associated substrates | Q24324381 | ||
| The docking protein HEF1 is an apoptotic mediator at focal adhesion sites | Q24553123 | ||
| A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1 | Q24595443 | ||
| CAS proteins in normal and pathological cell growth control | Q24630247 | ||
| HEF1-dependent Aurora A activation induces disassembly of the primary cilium | Q24647111 | ||
| A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9 | Q24656693 | ||
| Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling | Q24669865 | ||
| Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes | Q24676931 | ||
| Inhibition of Pyk2 blocks airway inflammation and hyperresponsiveness in a mouse model of asthma. | Q33766437 | ||
| Calcium signaling and amyloid toxicity in Alzheimer disease | Q33799937 | ||
| Pyk2 activation triggers epidermal growth factor receptor signaling and cell motility after wounding sheets of epithelial cells | Q33809899 | ||
| Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. | Q33822008 | ||
| Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans | Q33846034 | ||
| RAFTK/Pyk2-mediated cellular signalling | Q33855347 | ||
| Current status on Alzheimer disease molecular genetics: from past, to present, to future | Q33871345 | ||
| Mechanisms underlying hypoxia-induced neuronal apoptosis | Q33935219 | ||
| Multiple oxygen tension environments reveal diverse patterns of transcriptional regulation in primary astrocytes | Q33955205 | ||
| Aggregation of vascular risk factors and risk of incident Alzheimer disease | Q33989502 | ||
| Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals | Q34013528 | ||
| Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease | Q34016371 | ||
| Proline-rich tyrosine kinase-2 is critical for CD8 T-cell short-lived effector fate | Q34136306 | ||
| The WW-HECT protein Smurf2 interacts with the Docking Protein NEDD9/HEF1 for Aurora A activation. | Q34138871 | ||
| Targeting Pyk2 for therapeutic intervention | Q34146883 | ||
| The GDP exchange factor AND-34 is expressed in B cells, associates with HEF1, and activates Cdc42. | Q34169212 | ||
| Rapid calcium-dependent activation of Aurora-A kinase. | Q34239225 | ||
| Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer | Q34295621 | ||
| Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers | Q34396204 | ||
| The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas-like protein, p105HEF1. | Q34434204 | ||
| γ-secretase modulators and presenilin 1 mutants act differently on presenilin/γ-secretase function to cleave Aβ42 and Aβ43. | Q34537154 | ||
| Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons | Q34590202 | ||
| Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. | Q34748737 | ||
| Aurora A kinase activity influences calcium signaling in kidney cells | Q35047469 | ||
| The acetylation of tau inhibits its function and promotes pathological tau aggregation | Q35059866 | ||
| Targeted inhibition of FAK, PYK2 and BCL-XL synergistically enhances apoptosis in ovarian clear cell carcinoma cell lines | Q35093687 | ||
| Extended results of the Alzheimer's disease anti-inflammatory prevention trial | Q35146385 | ||
| Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney | Q35215135 | ||
| Pyk2 is required for neutrophil degranulation and host defense responses to bacterial infection | Q35640945 | ||
| Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease | Q35658184 | ||
| Inhibition of Pyk2 blocks lung inflammation and injury in a mouse model of acute lung injury | Q35744840 | ||
| Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy | Q35882137 | ||
| Genome-wide association study of primary open angle glaucoma risk and quantitative traits | Q35957011 | ||
| Angiotensin II revisited: new roles in inflammation, immunology and aging | Q36039299 | ||
| Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate | Q33596829 | ||
| ATP5H/KCTD2 locus is associated with Alzheimer's disease risk. | Q33652534 | ||
| Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model | Q33715257 | ||
| The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. | Q33751705 | ||
| Protein tyrosine kinase 2beta as a candidate gene for hypertension | Q46854007 | ||
| Alpha2beta1 and alphaVbeta1 integrin signaling pathways mediate amyloid-beta-induced neurotoxicity | Q46920848 | ||
| Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial | Q47343172 | ||
| Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study | Q47790444 | ||
| A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease | Q48181387 | ||
| A new paradigm for the treatment of Alzheimer's disease: targeting vascular activation. | Q50690290 | ||
| NEDD9 gene polymorphism influences the risk of Alzheimer disease and cognitive function in Chinese older persons. | Q51809705 | ||
| Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. | Q52061053 | ||
| Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. | Q52200995 | ||
| Characterization of the tyrosine kinases RAFTK/Pyk2 and FAK in nerve growth factor-induced neuronal differentiation. | Q52538801 | ||
| Mutations in TREM2 lead to pure early-onset dementia without bone cysts. | Q52587424 | ||
| Different PI 3-kinase inhibitors have distinct effects on endothelial permeability and leukocyte transmigration. | Q53155938 | ||
| Predisposing locus for Alzheimer's disease on chromosome 21. | Q53187559 | ||
| Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. | Q53349055 | ||
| Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. | Q53354093 | ||
| Global identification of the genes and pathways differentially expressed in hypothalamus in early and established neurogenic hypertension. | Q54378215 | ||
| Renal-Cell Carcinoma | Q56019528 | ||
| Systematic Analysis of Candidate Genes for Alzheimer's Disease in a French, Genome-Wide Association Study | Q57605743 | ||
| Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy | Q58477361 | ||
| Genetics of Alzheimer's disease | Q58920538 | ||
| Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons | Q73115038 | ||
| Role of calcium-sensitive tyrosine kinase Pyk2/CAKbeta/RAFTK in angiotensin II induced Ras/ERK signaling | Q77418880 | ||
| Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle | Q77426358 | ||
| Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cells | Q81656234 | ||
| Inflammation and Alzheimer's disease | Q82323473 | ||
| Renal cell carcinoma | Q82656838 | ||
| A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, | Q83608958 | ||
| US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 | Q84300422 | ||
| The Cas family docking protein, HEF1, promotes the formation of neurite-like membrane extensions | Q40340844 | ||
| VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells | Q40373217 | ||
| The tyrosine kinase pyk2 promotes migration and invasion of glioma cells. | Q40407170 | ||
| Phosphorylation of tau by fyn: implications for Alzheimer's disease. | Q40582507 | ||
| Calcitonin induces dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in osteoclasts | Q40704233 | ||
| Human endothelial Pyk2 is expressed in two isoforms and associates with paxillin and p130Cas | Q40753563 | ||
| Inhibition of PYK2-induced actin cytoskeleton reorganization, PYK2 autophosphorylation and focal adhesion targeting by FAK. | Q40771561 | ||
| Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins | Q40977784 | ||
| Mechanisms of neuronal degeneration in Alzheimer's disease | Q40986730 | ||
| T cell receptor engagement induces tyrosine phosphorylation of FAK and Pyk2 and their association with Lck. | Q41094192 | ||
| Cloning and Characterization of Cell Adhesion Kinase β, a Novel Protein-tyrosine Kinase of the Focal Adhesion Kinase Subfamily | Q41296563 | ||
| Role of NEDD9 in invasion and metastasis of lung adenocarcinoma | Q41323971 | ||
| Amyloid-β and Alzheimer's disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions | Q41880646 | ||
| The essential role of LIS1, NDEL1 and Aurora-A in polarity formation and microtubule organization during neurogensis | Q41957932 | ||
| It cuts two ways: microtubule loss during Alzheimer disease | Q41972657 | ||
| Altered PYK2 phosphorylation by ANG II in hypertensive vascular smooth muscle | Q42515619 | ||
| Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment? | Q42659546 | ||
| Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor | Q43575289 | ||
| CD44-initiated cell spreading induces Pyk2 phosphorylation, is mediated by Src family kinases, and is negatively regulated by CD45. | Q43615463 | ||
| Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia | Q43668225 | ||
| Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating beta-catenin tyrosine phosphorylation | Q43688548 | ||
| Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study | Q43820251 | ||
| The combined impact of 12 common variants on hypertension in Japanese men, considering GWAS results | Q44096786 | ||
| Abeta(25-35) and Abeta(1-40) act on different calcium channels in CA1 hippocampal neurons | Q44122940 | ||
| Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease | Q44191043 | ||
| Role of Crk-associated substrate lymphocyte type in the pathophysiology of rheumatoid arthritis in tax transgenic mice and in humans | Q44504448 | ||
| The metastasis gene NEDD9 product acts through integrin β3 and Src to promote mesenchymal motility and inhibit amoeboid motility | Q44929670 | ||
| Amplification of IFN-alpha-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors | Q45092703 | ||
| Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer | Q46625804 | ||
| Disease-related modifications in tau affect the interaction between Fyn and Tau. | Q46663739 | ||
| 'Tuning' of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages | Q46847122 | ||
| Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells | Q28281337 | ||
| HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells | Q28281874 | ||
| Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy | Q28282855 | ||
| Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent | Q28283260 | ||
| Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease | Q28285170 | ||
| VHL inactivation induces HEF1 and Aurora kinase A | Q28294037 | ||
| NEDD9 is genetically associated with Alzheimer's disease in a Han Chinese population | Q28297844 | ||
| Integrin signalling adaptors: not only figurants in the cancer story | Q28299126 | ||
| Rac activation and inactivation control plasticity of tumor cell movement | Q28299776 | ||
| Structural insights into the association between BCAR3 and Cas family members, an atypical complex implicated in anti-oestrogen resistance | Q28304848 | ||
| The optimal use of bexarotene in cutaneous T-cell lymphoma | Q28305252 | ||
| Cerebral ischemia and seizures induce tyrosine phosphorylation of PYK2 in neurons and microglial cells | Q28577298 | ||
| Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins | Q28582208 | ||
| Pyk2/CAKbeta tyrosine kinase activity-mediated angiogenesis of pulmonary vascular endothelial cells | Q28582472 | ||
| Divergent regulation of Pyk2/CAKbeta phosphorylation by Ca2+ and cAMP in the hippocampus | Q28583379 | ||
| An essential role of the aPKC-Aurora A-NDEL1 pathway in neurite elongation by modulation of microtubule dynamics | Q28585404 | ||
| NDEL1 phosphorylation by Aurora-A kinase is essential for centrosomal maturation, separation, and TACC3 recruitment | Q28587157 | ||
| Central role of calcium-dependent tyrosine kinase PYK2 in endothelial nitric oxide synthase-mediated angiogenic response and vascular function | Q28594535 | ||
| Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease | Q28742427 | ||
| Force Sensing by Mechanical Extension of the Src Family Kinase Substrate p130Cas | Q29030077 | ||
| Genome-wide association study of Alzheimer's disease | Q29417071 | ||
| GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease | Q29417137 | ||
| Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective | Q29614702 | ||
| Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease | Q29614881 | ||
| Focal adhesion kinase: in command and control of cell motility | Q29615192 | ||
| A general framework for estimating the relative pathogenicity of human genetic variants | Q29615730 | ||
| Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway | Q30168046 | ||
| c-Src signaling induced by the adapters Sin and Cas is mediated by Rap1 GTPase | Q30168758 | ||
| Integrin engagement, the actin cytoskeleton, and c-Src are required for the calcitonin-induced tyrosine phosphorylation of paxillin and HEF1, but not for calcitonin-induced Erk1/2 phosphorylation | Q30168812 | ||
| Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. | Q30410885 | ||
| Expression and characterization of splice variants of PYK2, a focal adhesion kinase-related protein. | Q30472274 | ||
| Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes | Q30530899 | ||
| Abl family kinases modulate T cell-mediated inflammation and chemokine-induced migration through the adaptor HEF1 and the GTPase Rap1 | Q30537824 | ||
| Human-specific transcriptional networks in the brain | Q30539579 | ||
| Glaucoma is associated with peripheral vascular endothelial dysfunction. | Q30839295 | ||
| The retinoic acid inducible Cas-family signaling protein Nedd9 regulates neural crest cell migration by modulating adhesion and actin dynamics | Q33554597 | ||
| Primary cilia in the developing and mature brain | Q27002324 | ||
| The pathobiology of vascular dementia | Q27006033 | ||
| Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways | Q27014964 | ||
| NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling | Q27675552 | ||
| Comprehensive molecular characterization of clear cell renal cell carcinoma | Q27852374 | ||
| Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 | ||
| Fyn and Lck tyrosine kinases regulate tyrosine phosphorylation of p105CasL, a member of the p130Cas docking protein family, in T-cell receptor-mediated signalling | Q28142155 | ||
| Cytoskeleton-dependent tyrosine phosphorylation of the p130(Cas) family member HEF1 downstream of the G protein-coupled calcitonin receptor. Calcitonin induces the association of HEF1, paxillin, and focal adhesion kinase | Q28142663 | ||
| Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades | Q28144135 | ||
| Identification of a set of genes with developmentally down-regulated expression in the mouse brain | Q28187594 | ||
| p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected] | Q28212545 | ||
| Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle | Q28241105 | ||
| The serine-rich domain from Crk-associated substrate (p130cas) is a four-helix bundle | Q28242010 | ||
| CAS proteins in health and disease: an update | Q28242737 | ||
| Transforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling component | Q28251271 | ||
| BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl | Q28257171 | ||
| Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7 | Q28257757 | ||
| Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease | Q28260161 | ||
| Paxillin phosphorylation and association with Lck and Pyk2 in anti-CD3- or anti-CD45-stimulated T cells | Q28263643 | ||
| T cell receptor-mediated tyrosine phosphorylation of Cas-L, a 105-kDa Crk-associated substrate-related protein, and its association of Crk and C3G | Q28264262 | ||
| A novel Cas family member, HEPL, regulates FAK and cell spreading | Q28267647 | ||
| Differential expression and dynamic changes of murine NEDD9 in progenitor cells of diverse tissues | Q28269124 | ||
| HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells | Q28270184 | ||
| The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome | Q28273944 | ||
| NEDD9 rs760678 polymorphism and the risk of Alzheimer's disease: a meta-analysis | Q28274763 | ||
| Nedd9 protein, a Cas-L homologue, is upregulated after transient global ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemia | Q28275942 | ||
| Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer | Q28276415 | ||
| All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos | Q28277857 | ||
| The hematopoietic isoform of Cas-Hef1-associated signal transducer regulates chemokine-induced inside-out signaling and T cell trafficking | Q28279398 | ||
| Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease | Q28280937 | ||
| Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton | Q28281154 | ||
| Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis | Q36091819 | ||
| Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics | Q36402212 | ||
| ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions | Q36835522 | ||
| The WAVE2 complex regulates T cell receptor signaling to integrins via Abl- and CrkL-C3G-mediated activation of Rap1. | Q36890122 | ||
| Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease | Q36914722 | ||
| The GSK3 hypothesis of Alzheimer's disease | Q37035378 | ||
| The aurora kinase A regulates GSK-3beta in gastric cancer cells | Q37096754 | ||
| Animal models of Alzheimer's disease and frontotemporal dementia | Q37196122 | ||
| Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons | Q37196206 | ||
| A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways | Q37267214 | ||
| Smurf2 induces degradation of GSK-3beta and upregulates beta-catenin in chondrocytes: a potential mechanism for Smurf2-induced degeneration of articular cartilage. | Q37288448 | ||
| Tau phosphorylation: the therapeutic challenge for neurodegenerative disease | Q37402114 | ||
| Microtubule assembly, organization and dynamics in axons and dendrites | Q37450792 | ||
| Biomarker modeling of Alzheimer's disease | Q37592824 | ||
| Hypoxia and neurodegeneration | Q37618864 | ||
| Emerging roles of Wnts in the adult nervous system | Q37654778 | ||
| FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumors | Q37707278 | ||
| Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer | Q37750751 | ||
| Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents? | Q37799220 | ||
| The genetics of Alzheimer disease: back to the future | Q37801081 | ||
| Psychotropic drug effects on gene transcriptomics relevant to Alzheimer disease | Q37852542 | ||
| Amyloid precursor protein processing and Alzheimer's disease | Q37860317 | ||
| Does vascular pathology contribute to Alzheimer changes? | Q38033859 | ||
| Alzheimer's disease: an update of the roles of receptors, astrocytes and primary cilia (review). | Q38057662 | ||
| Key developments in renin-angiotensin-aldosterone system inhibition. | Q38061004 | ||
| Primary cilia in neurodevelopmental disorders | Q38168054 | ||
| Review: The genetics of Alzheimer's disease; putting flesh on the bones | Q38180149 | ||
| Glial calcium signalling in Alzheimer's disease. | Q38220737 | ||
| Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase | Q38311339 | ||
| The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum | Q38344063 | ||
| NEDD9 regulates 3D migratory activity independent of the Rac1 morphology switch in glioma and neuroblastoma | Q39043526 | ||
| Retinoic acid induces adhesion and migration in NB4 cells through Pyk2 signaling | Q39166207 | ||
| TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. | Q39702429 | ||
| Identification of genes that regulate epithelial cell migration using an siRNA screening approach | Q39892281 | ||
| atRA Regulation of NEDD9, a gene involved in neurite outgrowth and cell adhesion | Q39967404 | ||
| P433 | issue | 7 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 486-503 | |
| P577 | publication date | 2014-07-23 | |
| P1433 | published in | Oncoscience | Q27725796 |
| P1476 | title | Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease | |
| P478 | volume | 1 |
| Q37676902 | A Cross-Disorder Method to Identify Novel Candidate Genes for Developmental Brain Disorders |
| Q64929096 | Alzheimer's genetic risk is reduced in primary age-related tauopathy: a potential model of resistance? |
| Q34295621 | Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer |
| Q57469887 | CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease |
| Q28646036 | Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members |
| Q54107709 | Exploring the mechanistic insights of Cas scaffolding protein family member 4 with protein tyrosine kinase 2 in Alzheimer's disease by evaluating protein interactions through molecular docking and dynamic simulations. |
| Q33726405 | Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology. |
| Q26747803 | Genes associated with Alzheimer's disease: an overview and current status |
| Q35872461 | Polygenic Analysis of Late-Onset Alzheimer's Disease from Mainland China |
| Q28085339 | Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases |
| Q55030378 | Probing the role of PPARγ in the regulation of late-onset Alzheimer's disease-associated genes. |
| Q39307376 | State of Play in Alzheimer's Disease Genetics |
| Q47171672 | Taming Alzheimer's disease: New perspectives, newer horizons |
| Q93077432 | The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis? |
Search more.